Image-guided radiotherapy (IGRT) is a technique used in radiation oncology to enhance the precision and accuracy of delivering radiation therapy to cancerous tumors. It involves the use of advanced imaging technologies to visualize the tumor and surrounding tissues in real-time during the treatment planning and delivery process.
Elekta and GE Healthcare two giants entered a global commercial collaboration in October 2023, offering healthcare providers a comprehensive solution for radiation oncology across imaging and treatment.
Varian Medical Systems and Brainlab Announced a strategic partnership in December 2023 to integrate Brainlab's artificial intelligence (AI)-powered surgical navigation technology with Varian's radiotherapy systems.
ViewRay expands its MRIdian Linac platform: November 2023, ViewRay launched the first commercially available dual-energy MRIdian Linac system, enabling real-time imaging during radiotherapy treatment for even greater precision.
Accuray Incorporated receives NMPA approval for Tomo C radiation therapy system: July 2023 approval in China expands Accuray's reach and offers a versatile IGRT option for lung and other cancers.
List of Image Guided Radiotherapy Key Companies in the Market
Market Scenario
The Image Guided Radiotherapy Market is anticipated to reach USD 4,854.6 Million by 2030 at 14.7% CAGR during the forecast period 2022-2030. Image guided radiotherapy (IGRT), a type of conformal radiotherapy, involves the use of different scans and X-rays to treat an area of cancer. Conformal radiotherapy shape the radiotherapy beams around the area of the cancerous tissue. It uses X-rays and scans similar to CT scans before and during the radiotherapy treatment. It improves the precision and accuracy of treatment delivery. These therapy are majorly used in the treatment of cancer such as lung cancer, skin cancer, and others. Increasing prevalence of cancer and rapid development in the cancer treatment drives the growth of the market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality worldwide. The data also suggest that about 14 million new cases observed in 2012, which is expected to increase by 70% till 2030. Apart from this, continuously rising demand for the better cancer treatment, increasing healthcare expenditure, and government encouragement for research & development expected to fuel the growth of the market over the corresponding period. On the other hand, high cost of the treatment & devices and side effects of the treatment may slow the market growth over the forecasted period.
Figure: Global Image guided radiotherapy market, by technology, 2016 (%) 
Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, market research future analysis, annual report, white paper, company presentation
Key Players
Some of the key players in the image guided radiotherapy market are ViewRay (US), General Electric Company (US), Hitachi, Ltd. (Japan), Siemens AG (Germany), Koninklijke Philips N.V. (Netherland), TOSHIBA CORPORATION (Japan), Varian Medical Systems, Inc. (US), Vision RT Ltd. (UK), Scranton Gillette Communications (US), XinRay Systems (US), and C-RAD (Sweden).
Segmentation
The global image guided radiotherapy market is segmented on the basis of types, technology, devices, application, and end users.
On the basis of types, the market is segmented into soft-tissue imaging, lung MRI, simplifying cardiac MRI, simplifying MRI-conditional implant scans, and silent MRI scanning.
On the basis of technology the market is segmented into radiation-based, non-radiation based systems, and others. Radiation-based system is further segmented into electronic portal imaging devices (EPID), cone beam CT, Fan beam, and others. Non-radiation based systems are further segmented into ultrasound-based systems, camera-based or optical tracking systems, MRI-guided IGRT, and others.
On the basis of devices, the market is segmented into X-ray computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography, and others. X-ray computed tomography market is further segmented into digital X-ray, computed tomography (CT), conventional CT, optical tracking, cone beam, MVCT, and others.
On the basis of end users, the market is segmented in hospitals, smart cancer centers, research institutes, and others.
Research Methodology:
Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, market research future analysis, annual report, white paper, company presentation
Regional Analysis
The Americas account for the largest share in the global image guided radiotherapy market owing to the presence of huge patient population and increasing healthcare expenditure. According to the American Cancer Society, in 2016, over 1,688,780 cancer cases were diagnosed in the America. Moreover, increasing awareness among the people and well-developed technology have fuelled the market growth. Europe is the second largest market and holds a noticeable share in the global image guided radiotherapy market. The European market is expected to grow significantly during the forecast period owing to availability of advanced treatment facilities, skilled medical professionals, and the government support for research & development. Asia Pacific accounts for the fastest growing market owing to increasing prevalence of cancer, rising awareness about the cancer, and availability of new treatment methods. In Asia Pacific, the market shows growth opportunities in China and India. However, the Middle East & Africa is expected to show the least growth in this market due to lack of awareness, limited development in healthcare technology, and availability of treatment facilities
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)